Recent Finacing
Recent Raise
Myonexus Therapeutics is a clinical-stage biotech developing gene therapies for multiple limb-girdle muscular dystrophy subtypes, advancing a multi-program pipeline across preclinical and Phase 1/2a clinical stages.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
